Yuzawa Y, Watanabe Y
Third department of Internal Medicine, Nagoya University School of Medicine.
Nihon Rinsho. 1995 Apr;53(4):864-9.
Hypercalcemia accompanying with the elevation of parathyroid hormone (PTH) is critical for the differentiation of primary hyperparathyroidism (I HPT) from other diseases which show hypercalcemia. Recently, the reliable immunoassays for PTH especially for intact-PTH have been established and widely introduced in the clinical field. Marked development of cellular and molecular biology also contribute to the exploration of the mechanism of calcium/bone metabolism. The diagnosis of I HPT can be easily established in some patients by their typical clinical findings. Many of them, however, usually show asymptomatic hypercalcemia while some patients show normocalcemia. It is highly important to evaluate the parathyroid function precisely by several biochemical or hormonal parameters related to calcium metabolism for complete diagnosis and treatment.
伴有甲状旁腺激素(PTH)升高的高钙血症对于原发性甲状旁腺功能亢进症(I HPT)与其他表现为高钙血症的疾病的鉴别诊断至关重要。近年来,已建立了可靠的PTH免疫测定方法,尤其是完整PTH的免疫测定方法,并在临床领域广泛应用。细胞生物学和分子生物学的显著发展也有助于探索钙/骨代谢的机制。一些患者通过典型的临床表现可轻松确诊I HPT。然而,他们中的许多人通常表现为无症状性高钙血症,而一些患者则表现为血钙正常。通过与钙代谢相关的多种生化或激素参数精确评估甲状旁腺功能对于完整的诊断和治疗至关重要。